ARTICLE SUMMARY:
Medtech start-ups are shifting away from traditional therapeutic devices toward proactive care solutions, with a heavy emphasis on advanced digital capabilities, according to a recent analysis from Deloitte Consulting and MedTech Innovator (MTI). In the following Q&A, Glenn Snyder of Deloitte and Paul Grand of MTI delve into the findings and what they mean for the future of medtech innovation.
A recent analysis from Deloitte Consulting, in collaboration with MedTech Innovator (MTI), finds that medtech start-ups are rapidly shifting their focus away from treatment solutions and toward disease prevention, detection/diagnosis, and post-acute and chronic care, with a heavy emphasis on incorporating advanced digital capabilities. The analysis offers insights into the current state of the medtech start-up ecosystem and how innovators are adapting to address the evolving patient journey.
